Active Biotech AB

Active Biotech AB
Stock Exchange Frankfurt Stock Exchange
EPS
-
Market Cap
-
Shares Outstanding
145.24 M
Public Float
-
Active Biotech AB
Stock Exchange OTC Publication Venue
EPS
SEK0.25
Market Cap
SEK446.6 M
Shares Outstanding
145.24 M
Public Float
86.64 M

Profile

Address
Scheelevägen 22
Lund SN 223 63
Sweden
Employees -
Website http://www.activebiotech.com
Updated 07/08/2019
Active Biotech AB develops pharmaceutical preparations. It develops pharmaceutical products within medical areas where the immune defense is of significant importance, including neurodegenerative diseases, autoimmune, inflammatory disease and various forms of cancer. The company's project portfolio comprises small, orally active immunomodulatory molecules as well as antibody-based immunotherapy.

Financials

View All
Created with Highcharts 5.0.14Active Biotech ABNet Income. Fiscal year is January-December. All values SEK Thousands.212 086212 086231 512231 512193 531193 53159 58459 584108 793108 79336 87836 878201320142015201620172018050k100k150k200k250k
Created with Highcharts 5.0.14Active Biotech ABSales/Revenue. Fiscal year is January-December. All values SEK Thousands.115 970115 97010 39910 39916 27516 27519 04219 0425 2065 20620 05120 051201320142015201620172018025k50k75k100k125k

Mats Arnhög
Chairman
Magnhild Sandberg-Wollheim
Director